By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Peptide and antibody maker Cambridge Research Biochemicals has extended a license agreement with Life Technologies that enables it to use the company's Molecular Probes line of dyes, CRB said today.

The extension of the agreement, originally formed in 2007, extends CRB's license to offer dye-labeled primary antibodies as well as peptides, the Billingham, UK-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.